Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Orchestra BioMed Holdings, Inc. | Chief Financial Officer | Common Stock, par value $0.0001 per share ("Common Stock") | 378K | $301K | $1.08 | May 8, 2024 | Direct |
Motus GI Holdings, Inc. | Chief Financial Officer | Common Stock, par value $0.0001 per share | 231K | $118K | $0.51 | Feb 10, 2022 | Direct |
Motus GI Holdings, Inc. | Chief Financial Officer | Stock Option (right to buy) | 95K | Feb 10, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OBIO | Orchestra BioMed Holdings, Inc. | May 8, 2024 | 1 | $0 | 4 | May 10, 2024 | Chief Financial Officer |
OBIO | Orchestra BioMed Holdings, Inc. | Jul 20, 2023 | 1 | $0 | 4 | Jul 24, 2023 | Chief Financial Officer |
OBIO | Orchestra BioMed Holdings, Inc. | Jun 6, 2023 | 0 | $0 | 3 | Jun 12, 2023 | Chief Financial Officer |
MOTS | Motus GI Holdings, Inc. | Feb 10, 2022 | 2 | $0 | 4 | Feb 11, 2022 | Chief Financial Officer |
MOTS | Motus GI Holdings, Inc. | Nov 19, 2021 | 1 | $1.02K | 4 | Nov 22, 2021 | Chief Financial Officer |